Invention Application
- Patent Title: DIFFOCIN AND METHODS OF USE THEREOF
- Patent Title (中): 差异及其使用方法
-
Application No.: US13117467Application Date: 2011-05-27
-
Publication No.: US20110293566A1Publication Date: 2011-12-01
- Inventor: Dean M. SCHOLL , Dana M. Gebhart , Steven R. Williams , Gregory R. Govoni , David W. Martin, JR.
- Applicant: Dean M. SCHOLL , Dana M. Gebhart , Steven R. Williams , Gregory R. Govoni , David W. Martin, JR.
- Applicant Address: US CA South San Francisco
- Assignee: AvidBiotics Corp.
- Current Assignee: AvidBiotics Corp.
- Current Assignee Address: US CA South San Francisco
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/33 ; C12P21/02 ; A61K35/00 ; C12N15/74 ; C12N1/21 ; C07H21/04 ; A61P31/04

Abstract:
This disclosure relates to the discovery and isolation of the entire cluster of genes encoding R-type high molecular weight bacteriocins that specifically kill Clostridium difficile bacteria, dangerous human pathogens. Also disclosed are methods of producing the R-type bacteriocins in innocuous producer cells that, unlike C. difficile, do not die in the presence of oxygen. Disclosed also is the specific gene of the isolated gene cluster that determines the killing spectrum of the R-type bacteriocin and the demonstration that the killing spectra of diffocins can be altered by engineering orf1374 of the diffocin genetic locus. This invention offers a potent bactericidal agent and a means to make it in order to kill selectively C. difficile bacteria in the environment of the gastrointestinal tract where they can cause great harm and even death of the infected patient or farm animal.
Public/Granted literature
- US08673291B2 Diffocin and methods of use thereof Public/Granted day:2014-03-18
Information query
IPC分类: